KCNJ11 polymorphisms and sudden cardiac death in patients with acute myocardial infarction

A Jeron1, C Hengstenberg, S Holmer

  • 1Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg 93042, Germany. andreas.jeron@klinik.uni-regensburg.de

Insights

Polymorphisms in the KCNJ11 gene were not linked to sudden cardiac death (SCD) in acute myocardial infarction (AMI) patients. This study found no significant differences in gene variants between survivors and those who experienced SCD.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology

Background:

  • Acute myocardial infarction (AMI) patients face a high risk of sudden cardiac death (SCD) due to ischemia-induced ventricular arrhythmias.
  • Genetic variations, particularly in ion channel genes, may influence individual susceptibility to these arrhythmias.
  • The cardiac ATP-dependent potassium channel (K(ATP)), encoded by KCNJ11 and SUR2a, plays a role in cardiac action potential duration during ischemia.

Purpose of the Study:

  • To investigate the association between KCNJ11 gene polymorphisms and the risk of SCD in patients following an acute myocardial infarction.
  • To determine if specific KCNJ11 gene variants correlate with the occurrence of fatal ventricular arrhythmias after AMI.

Main Methods:

  • Prospective sequencing of the complete coding and adjacent regions of the intronless KCNJ11 gene in two patient groups.
  • Group 1 comprised 84 AMI survivors without ventricular arrhythmias; Group 2 included 86 AMI patients who died from SCD.
  • Analysis of allele, genotype, and haplotype frequencies for identified polymorphisms and novel mutations.

Main Results:

  • Six known and two novel polymorphisms in the KCNJ11 gene were identified.
  • No significant differences in allele, genotype, or haplotype frequencies were observed between the SCD and survivor groups.
  • Two novel missense mutations (P266T, R371H) were found in SCD patients, but their functional impact remains unknown.

Conclusions:

  • Polymorphisms within the KCNJ11 gene are not associated with sudden cardiac death in the studied population of acute myocardial infarction patients.
  • The findings suggest that KCNJ11 variations do not play a significant role in the risk of SCD following AMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.